Home
Resources
Publications
Role of mGlu7 Receptor in Morphine Rewarding Effects Is Uncovered by a Novel Orthosteric Agonist

Role of mGlu7 Receptor in Morphine Rewarding Effects Is Uncovered by a Novel Orthosteric Agonist

Zuzana Hajasova, Corinne Canestrelli, Francine Acher, Florence Noble, Nicolas Marie

Neuropharmacology. 2018 Mar 15;131:424-430.

PMID: 29307544

Abstract:

Opiate dependence is a major health issue and despite the existence of opioid substitution treatment, relapse frequently occurs. Group III metabotropic glutamate (mGlu) receptors has received much attention as a putative target in ethanol and cocaine addiction, but no data on opiate addiction exist. So we investigated the role of group III mGlu receptors in morphine rewarding effects through the expression and the reinstatement of conditioned place preference (CPP) using a newly synthesized mGlu4/mGlu7 receptor orthosteric agonist, LSP2-9166. We found that LSP2-9166 blocked morphine CPP expression and reinstatement after extinction. Blockade of CPP expression with LSP2-9166 was abolished when using XAP044, a mGlu7 antagonist. We also found that LSP2-9166 at the dose active for blocking morphine reward was devoid of any effect on locomotion, hedonic state, spatial memory, anxiety or depression. Altogether our data demonstrated that group III mGlu receptors, and more specifically mGlu7, might be a valuable target in opiate addiction.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP196928504	XAP044		196928-50-4	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: